Synta Pharmaceuticals Corp. (SNTA): More Good News: Synta Pharmaceuticals Could Be A Triple Bagger - Seeking Alpha
Here is an excellent article on SNTA, a biotech stock. I only own two drug stocks, but SNTA looks very interesting. It might be worthwhile buying it on pullbacks, but you would need to keep researching the company to avoid possible capital losses. A lot of biotech stocks crash before their drug is ever approved.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment